NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Comprehensive Nano - Post Market Clinical Follow-Up Study
Comprehensive Nano - Post Market Clinical Follow-Up Study

NCT03423953

Active Not RecruitingN/A

Sponsor: Zimmer Biomet

Conditions: Osteoarthritis, Avascular Necrosis, Rheumatoid Arthritis, Revision, Correction of Functional Deformity

Interventions: Comprehensive Nano

Countries: Austria, Canada, South Korea, United Kingdom

This data collection project is intended to provide clinical outcomes data to engineering, marketing as well as fulfill the post market surveillance requirements of various regulatory authorities. The study will be a prospective and one-arm.

Eligibility overview

Sex: ALL

Age: 18 Years to

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis.
* Rheumatoid arthritis
* Revision where other devices or treatments have failed
* Correction of functional deformity.
* Difficult clinical management problems where other methods of treatment may not be suitable or may be inadequate
* Difficult clinical management problems where other methods of treatment may not be suitable or may be inadequate

Exclusion Criteria:

* Infection
* Sepsis
* osteomyelitis
Locations (5)
  • Graz, Styria, Austria
  • Kingston, Ontario, Canada
  • Gwangju, Gwangju, South Korea
  • Seoul, Seoul, South Korea
  • Liverpool, Merseyside, United Kingdom